Zydus Lifesciences gets FDA final approval for BP drug generic version

Pallavi Madhiraju- November 9, 2022

Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg ... Read More

Zydus Lifesciences gets FDA EIR with VAI for Moraiya formulations plant

Pallavi Madhiraju- November 7, 2022

Zydus Lifesciences said that the US Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its Moraiya formulations manufacturing plant near ... Read More

Zydus Lifesciences gets FDA final approval for Ofirmev generic

Pallavi Madhiraju- October 30, 2022

Zydus Lifesciences Limited (formerly Cadila Healthcare) said that it has secured final approval from the US Food and Drug Administration (FDA) for Acetaminophen Injection, 1,000 ... Read More

Zydus Lifesciences gets FDA final approval for Micafungin for Injection

Pallavi Madhiraju- October 26, 2022

Zydus Lifesciences (formerly Cadila Healthcare) has secured final approval for Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials from the US Food and ... Read More

Zydus Lifesciences gets FDA final approval for Toradol generic

Pallavi Madhiraju- October 23, 2022

Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has secured final approval for its analgesic drug Ketorolac Tromethamine Tablets USP, 10 mg from the US Food ... Read More

Zydus Lifesciences gets FDA tentative approval for Valbenazine Capsules

Pallavi Madhiraju- October 17, 2022

Zydus Lifesciences (previously called Cadila Healthcare) said that its subsidiary Zydus Worldwide DMCC has been given tentative approval from the US Food and Drug Administration ... Read More

Zydus Lifesciences gets FDA final approval for Brivaracetam generic

Pallavi Madhiraju- October 6, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 ... Read More

Zydus Lifesciences gets final FDA approval for Mirabegron generic

Pallavi Madhiraju- October 4, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More

Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug

Pallavi Madhiraju- October 2, 2022

Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the ... Read More

Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

pallavi123- September 20, 2022

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More